Position in ASND
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$373,561,364
+$53,998,336 QoQ
Shares Held
1,400,575
+0.2% QoQ
Ownership
2.14%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#13
of 307 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 88%
Shared 12%
None 0%
Common Shares in ASND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AMERICAN CENTURY COMPANIES INC holds $3,568,637,643 across 178 Biotechnology names. ASND ranks #2 (10.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,853,956 | $558,096,374 | |
| 2 | ASND |
Ascendis Pharma A/S
This page
|
1,400,575 | $373,561,364 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
580,901 | $288,550,953 | |
| 4 | ARGX |
Argenx SE
|
173,193 | $160,683,269 | |
| 5 | IONS |
Ionis Pharmaceuticals Inc
|
1,947,076 | $154,383,656 | |
| 6 | EXEL |
Exelixis, Inc.
|
1,791,664 | $97,484,438 | |
| 7 | HRMY |
Harmony Biosciences Holdings, Inc.
|
2,539,512 | $92,463,631 | |
| 8 | GPCR |
Structure Therapeutics Inc.
|
1,682,179 | $90,282,546 |
All Filings in ASND
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $373,561,364 | 1,400,575 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $319,563,028 | 1,397,119 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $307,735,386 | 1,443,141 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $108,273,118 | 544,606 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $91,617,633 | 530,809 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $72,033,972 | 462,171 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $56,072,164 | 407,294 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $51,772,645 | 346,746 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $41,728,734 | 305,974 | Shares | Defined | 2024-08-07 | |
| 2024-03-31 | $46,279,334 | 306,141 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $38,759,475 | 307,737 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $30,833,217 | 329,274 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $32,341,165 | 362,366 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $38,238,619 | 356,637 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $41,975,348 | 343,694 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $35,376,876 | 342,600 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $31,651,578 | 340,486 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $41,410,006 | 352,846 | Shares | Defined | 2022-05-11 | |
| 2021-12-31 | $43,345,296 | 322,198 | Shares | Defined | 2022-02-07 | |
| 2021-09-30 | $44,044,716 | 276,333 | Shares | Defined | 2021-11-10 | |
| 2021-06-30 | $34,216,549 | 260,103 | Shares | Defined | 2021-08-05 | |
| 2021-03-31 | $25,696,481 | 199,383 | Shares | Defined | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||